| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,895 |
11,576 |
$1.92M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,890 |
7,018 |
$1.78M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,766 |
1,544 |
$452K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,132 |
2,905 |
$169K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,490 |
1,367 |
$112K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,857 |
1,727 |
$56K |
| 80053 |
Comprehensive metabolic panel |
3,553 |
3,475 |
$53K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
706 |
681 |
$53K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,260 |
1,228 |
$51K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
831 |
829 |
$40K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
425 |
418 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
567 |
559 |
$33K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
288 |
284 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,279 |
4,122 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,020 |
1,013 |
$26K |
| 87430 |
|
1,488 |
1,478 |
$22K |
| 87276 |
|
1,524 |
1,512 |
$21K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
547 |
536 |
$20K |
| 80305 |
|
1,532 |
1,501 |
$17K |
| 99222 |
Initial hospital care, per day, moderate complexity |
259 |
254 |
$16K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,695 |
2,459 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
962 |
952 |
$14K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
566 |
238 |
$14K |
| 71045 |
Radiologic examination, chest; single view |
975 |
962 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
3,718 |
3,514 |
$11K |
| 81025 |
|
1,321 |
1,300 |
$11K |
| 70450 |
Computed tomography, head or brain; without contrast material |
214 |
213 |
$11K |
| 87070 |
|
853 |
847 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
79 |
79 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
378 |
377 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
112 |
112 |
$5K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
112 |
112 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
49 |
49 |
$4K |
| 99217 |
|
86 |
86 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
103 |
102 |
$3K |
| 81003 |
|
1,525 |
1,502 |
$3K |
| 86756 |
|
187 |
187 |
$3K |
| 71250 |
|
39 |
38 |
$2K |
| 80061 |
Lipid panel |
237 |
236 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
165 |
164 |
$2K |
| 81001 |
|
678 |
664 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
325 |
321 |
$2K |
| 84481 |
|
151 |
150 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
20 |
13 |
$1K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
167 |
77 |
$923.36 |
| 84439 |
|
97 |
96 |
$638.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
94 |
94 |
$629.18 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$499.02 |
| 83690 |
|
79 |
78 |
$472.01 |
| 87807 |
|
39 |
39 |
$437.51 |
| 84484 |
|
36 |
36 |
$414.16 |
| 85027 |
|
71 |
71 |
$413.03 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
56 |
55 |
$405.26 |
| 99406 |
|
29 |
29 |
$400.78 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
12 |
12 |
$399.75 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
57 |
49 |
$397.46 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13 |
12 |
$389.65 |
| 73130 |
|
14 |
14 |
$329.61 |
| 82150 |
|
41 |
40 |
$236.16 |
| 87075 |
|
20 |
20 |
$168.40 |
| 82550 |
|
28 |
28 |
$144.75 |
| 83735 |
|
24 |
24 |
$137.08 |
| 82553 |
|
12 |
12 |
$134.21 |
| 87205 |
|
20 |
20 |
$76.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13 |
13 |
$4.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
217 |
217 |
$0.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
63 |
63 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
69 |
69 |
$0.00 |